- Email: [email protected]
310265 Immunoassay test kit
Comp. lmmun. Microbiol. infect. Dis. Vol. 14, No. 1, pp. i-xviii, 1991 Pergamon Press plc. Printed in Great Britain
NEW PATENTS This Section contains abstracts and, where appropriate, illustrations of recently issued United States patents and published patent applications filed from over 30 countries under the Patent Cooperation Treaty. This information was obtained from recent additions to the Pergamon PATSEARCH ® online database in accordance with interest profiles developed by the Editors. Further information about Pergamon PATSEARCH ® can be obtained from Pergamon Orbit InfoLine Inc., 8000 Westpark Drive, McLean, Virginia 22102, U.S.A. Copies of complete patents announced in this Section are available from Pergamon Orbit InfoLine Inc. for $8 per copy. Payment with order is required. Orders outside North America add $2 for air postage. Order by patent number for Pergamon Orbit lnfoLine only.
310265 IMMUNOASSAY
TEST KIT
Dennis M Mochnal, Henry A Graham, Walter Yarrow, C Minot Dole, Joseph R Paradis assigned to Ortho Diagnostic Systems Inc The ornamental design for an immunoassay test kit, as shown and described.
4944942 INTRANASAL VACCINATION OF HORSES WITH INACTIVATED MICROORGANISMS OR ANTIGENIC MATERIAL
The present invention relates to a method for the detection and quantification of lipoprotein(a) present in a fluid sample which method is not sensitive to the presence of plasminogen and which comprises contacting the fluid sample with anti-apo(a) antibody and forming a first immobilized complex of lipoprotein(a)/anti-apo(a) first antibody, contacting said first complex with anti-apo B second antibody and thereafter quantitating Lp(a) based on the amount of bound anti-apo B antibody. Immobilized rabbit antihuman apo(a) antibody can be employed as the first, capture, antibody and goat-anti-human apo B antibody as the second antibody. The amount of anti-apo B antibody bound is quantitated through binding of a third antibody/enzyme conjugate, e.g., a rabbit anti-goat antibody/alkaline phosphatase conjugate, followed by reaction with a suitable enzyme substrate such as paranitrophenyl phosphate.
Karen Brown, Sharon A Bryant assigned to Mobay Corporation Horses can be immunized by the intranasal administration of antigenic material which provokes the proliferation of antibodies which reduce or neutralize the virulence of invasive microorganisms. These antigenic materials may be inactivated whole organisms, extracts from such organisms, or recombinant D N A or synthetic peptide antigens. This antigenic material can be combined with adjuvants and transdermal carriers or it can just be carried in sterile water. The intranasal vaccination may be part of a total regimen that includes other routes of administration such as intramuscular injection.
4945040 IMMUNOASSAY FOR LIPOPROTEIN(A) Gunther M Fless, Angelo M Scanu assigned to Arch Development Corporation
4945041 MONOCLONAL ANTIBODIES FOR MYCOPLASMA PNEUMONIAE AND USE FOR DIAGNOSIS OF PNEUMONIA Joel B Baseman assigned to Board of Regents Monoclonal antibodies specific for Mycoplasma pneumoniae determinants and their use in the diagnosis of mycoplasma pneumoniae and purification of a protein determinant of M. pneumoniae.
NEW PATENTS This Section contains abstracts and, where appropriate, illustrations of recently issued United States patents and published patent applications filed from over 30 countries under the Patent Cooperation Treaty. This information was obtained from recent additions to the Pergamon PATSEARCH ® online database in accordance with interest profiles developed by the Editors. Further information about Pergamon PATSEARCH ® can be obtained from Pergamon Orbit InfoLine Inc., 8000 Westpark Drive, McLean, Virginia 22102, U.S.A. Copies of complete patents announced in this Section are available from Pergamon Orbit InfoLine Inc. for $8 per copy. Payment with order is required. Orders outside North America add $2 for air postage. Order by patent number for Pergamon Orbit lnfoLine only.
310265 IMMUNOASSAY
TEST KIT
Dennis M Mochnal, Henry A Graham, Walter Yarrow, C Minot Dole, Joseph R Paradis assigned to Ortho Diagnostic Systems Inc The ornamental design for an immunoassay test kit, as shown and described.
4944942 INTRANASAL VACCINATION OF HORSES WITH INACTIVATED MICROORGANISMS OR ANTIGENIC MATERIAL
The present invention relates to a method for the detection and quantification of lipoprotein(a) present in a fluid sample which method is not sensitive to the presence of plasminogen and which comprises contacting the fluid sample with anti-apo(a) antibody and forming a first immobilized complex of lipoprotein(a)/anti-apo(a) first antibody, contacting said first complex with anti-apo B second antibody and thereafter quantitating Lp(a) based on the amount of bound anti-apo B antibody. Immobilized rabbit antihuman apo(a) antibody can be employed as the first, capture, antibody and goat-anti-human apo B antibody as the second antibody. The amount of anti-apo B antibody bound is quantitated through binding of a third antibody/enzyme conjugate, e.g., a rabbit anti-goat antibody/alkaline phosphatase conjugate, followed by reaction with a suitable enzyme substrate such as paranitrophenyl phosphate.
Karen Brown, Sharon A Bryant assigned to Mobay Corporation Horses can be immunized by the intranasal administration of antigenic material which provokes the proliferation of antibodies which reduce or neutralize the virulence of invasive microorganisms. These antigenic materials may be inactivated whole organisms, extracts from such organisms, or recombinant D N A or synthetic peptide antigens. This antigenic material can be combined with adjuvants and transdermal carriers or it can just be carried in sterile water. The intranasal vaccination may be part of a total regimen that includes other routes of administration such as intramuscular injection.
4945040 IMMUNOASSAY FOR LIPOPROTEIN(A) Gunther M Fless, Angelo M Scanu assigned to Arch Development Corporation
4945041 MONOCLONAL ANTIBODIES FOR MYCOPLASMA PNEUMONIAE AND USE FOR DIAGNOSIS OF PNEUMONIA Joel B Baseman assigned to Board of Regents Monoclonal antibodies specific for Mycoplasma pneumoniae determinants and their use in the diagnosis of mycoplasma pneumoniae and purification of a protein determinant of M. pneumoniae.